- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: MEDI6383
Total 34 results
-
MedImmune LLCCompletedRecurrent or Metastatic Solid TumorsUnited States, Australia
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
MedImmune LLCCompletedRenal InsufficiencyNew Zealand, Germany
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedHealthy VolunteersGermany
-
MedImmune LLCCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom, South Africa
-
MedImmune LLCCompletedType 2 Diabetes MellitusUnited States
-
MedImmune LLCCompletedObesity | Diabetes Mellitus, Type IIUnited Kingdom
-
MedImmune LLCCompletedHealthy Subjects | SafetyUnited States
-
MedImmune LLCCompletedType 2 Diabetes MellitusGermany
-
MedImmune LLCCompletedType 2 Diabetes MellitusGermany
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
AstraZenecaMedImmune LLCCompletedDiabetes Mellitus, Type 2Germany, United States, Canada, Russian Federation, Slovakia, Czechia, Bulgaria, Mexico
-
MedImmune LLCCompletedRenal Insufficiency | Type II Diabetes MellitusUnited Kingdom, Germany
-
AstraZenecaCompletedChronic Kidney Diseases | Type 2 Diabetes MellitusSpain, United Kingdom, New Zealand, Australia, Canada, Poland, Germany, Japan
-
MedImmune LLCCompletedType 2 Diabetes MellitusHungary, Germany, United Kingdom
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Australia
-
MedImmune LLCCompletedType 2 Diabetes MellitusNetherlands, Sweden
-
MedImmune LLCCompletedHealthy VolunteersUnited States
-
CoMentisJuvenile Diabetes Research FoundationCompleted
-
Yale UniversityNational Alliance for Research on Schizophrenia and DepressionCompletedDepression | Alcohol DependenceUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute LeukemiaUnited States
-
OHSU Knight Cancer InstituteAbbVie; Oregon Health and Science UniversityRecruitingB Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Mixed Phenotype Acute LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States
-
National Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Puerto Rico, Israel
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States, Canada, Israel, Puerto Rico
-
National Cancer Institute (NCI)Not yet recruiting
-
National Cancer Institute (NCI)Active, not recruitingRecurrent B Acute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
National Cancer Institute (NCI)RecruitingDown Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic LymphomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage